New Depo-Provera Study Finds Link to Meningioma

Developed by Pfizer, Depo-Provera is a prescription birth control injection designed to prevent pregnancy. It’s administered once every three months and works through multiple mechanisms:

• Suppressing ovulation to stop egg release
• Thickening cervical mucus to block sperm
• Thinning the uterine lining to reduce the likelihood of implantation

The FDA approved the medication in 1992. It contains medroxyprogesterone acetate (MPA), a synthetic progestogen. It was marketed to patients as a reliable, convenient contraceptive f with a long-acting formulation that did not require the compliance of taking a daily birth control pill.

Medical professionals have monitored the drug’s long-term side effects for decades. Concerns have included bone density loss, changes in menstrual cycles and potential hormonal impacts. Most risks historically centered on reproductive health and metabolic effects.

Recent scientific studies have shifted focus to neurological impacts within the skull (intracranial). A newly released study looked at meningiomas, which are slow-growing tumors in the membranes surrounding the brain. Research suggests that the progesterone receptors in these tumors may be affected by Depo-Provera. Whether synthetic progestogens like MPA may contribute to meningioma development needs more research.

A recent Journal of the American Medical Association (JAMA) Neurology publication represents one of the largest case-control evaluations to date. It examines the potential connection between long-term Depo-Provera use and intracranial meningioma. Researchers analyzed a significant patient population across U.S. health systems. They compared contraceptive histories in women with and without meningioma diagnoses.

Key findings include:

• Long-term Depo-Provera use was linked with increased meningioma risk.
• Use of Depo-Provera for longer than 5 years had the strongest link.
• Risk increased the longer and more often a patient used the medication.
• The link between Depo-Provera and these tumors makes biological sense. Many meningiomas have receptors that respond to hormones like MPA.

Researchers noted that meningiomas may respond to long-term hormonal stimulation. MPA, a synthetic form of progesterone, could influence cell growth in susceptible tissues.

The study indicates a significant link between Depo-Provera and meningiomas. It doesn't state that the medication causes tumors. The data suggest that longer use may increase the risk of developing these tumors.

Depo-Provera meningioma lawsuits claim that long-term use of the birth control product led to the development of brain tumors. Plaintiffs argue that manufacturers didn't adequately warn patients and physicians about potential risks.

The new study provides:

• Scientific reinforcement for allegations previously considered speculative
• Potential for renewed case filings citing strengthened epidemiological evidence
• Increased scrutiny on Depo-Provera’s risk disclosures and labeling practices
• Possible calls for revised warnings or stronger patient counseling requirements

Lawsuits claim that Depo-Provera’s makers did not clearly warn about the risk of meningioma linked to long-term hormone exposure. With this new research available, attorneys for affected patients may use the findings to support their cases.

This stronger link between Depo-Provera and meningioma could lead to changes:

• Health agencies and medical groups may review or update their recommendations on how long Depo-Provera should be used.
• New research findings often shape how lawyers argue that a drug caused harm, though each lawsuit depends on its specific facts.
• People who used the drug long-term may be more likely to file claims.

Motley Rice represents individuals and families pursuing justice for injuries linked to medical devices and contraceptive products. Our attorneys have experience handling complex cases involving hormonal medications, long-term safety concerns and emerging scientific evidence.

To learn more about our experience and ongoing efforts to hold manufacturers like Pfizer accountable, read more about our involvement in birth control injury lawsuits.

Do not stop taking a prescribed medication without first consulting with your doctor. Discontinuing a prescribed medication without your doctor’s advice can result in injury or death. Depo-Provera remains approved by the U.S. Food and Drug Administration.